| SEQ_NO | 1 | Date of announcement | 2025/07/01 | Time of announcement | 03:20:12 |
| Subject | Receiving the Complaint Requesting to Attend Mediation | ||||
| Date of events | 2025/06/30 | To which item it meets | paragraph 2 | ||
| Statement | 1.Parties to the legal matter: Securities and Futures Investors Protection Center (‘SFIPC’), Jung Chin Lin, Medeon Biodesign, Inc., Wechen Co., Ltd., Pei-Chen Tsai, and Center Laboratories, Inc. 2.Name of the court or punishing agency of the legal matter: Intellectual Property and Commercial Court 3.Reference/Case number of relevant documents of the legal matter: 2025 Commercial Case Mediation No. 18. 4.Date of occurrence of the event:2025/06/30 5.Details of occurrence (including the matter under dispute): SFIPC claims for discharging Jung Chin Lin’s directorship in the Company. 6.Handling procedure:Mediation Notice Received. 7.Impact on the Company’s finance and business and projected amount: No impact on the finance and operation of the Company. 8.Countermeasures and improvement status: Engaging legal counsel for advice and subsequent solutions. 9.Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 2 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):None |
||||